- Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease: A Systematic Review and Retrospective Individual Participant–Level Meta-analysis of Clinical Trials Elaine Ku, MD et.al. Annals of Internal Medicine
- Semaglutide in patients with kidney failure and obesity undergoing dialysis and wishing to be transplanted: A prospective, observational, open-label study Lenka Vanek MD et.al. Diabetes Obes Metab. 2024
- Glucagon-like Peptide-1 Receptor Agonists: New Evidence of Kidney and Cardiovascular Protection From the FLOW and SELECT Trials Maarten W. Taal et.al. AJKD 2025
- Treatment strategies to reduce cardiovascular risk in persons with chronic kidney disease and Type 2 diabetes Faiez Zannad et.al.
- Hyperglycemic Crises in Adults With Diabetes: A Consensus Report Diabetes Care 2024
Continuous Glucose Monitoring and Reduced Diabetes-Related Hospitalizations in Patients with Type 2 Diabetes and CKD Katia L. Hannah et.al. Kidney360
- Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Vlado Perkovic et.al. NEJM 2025
- Challenges and Strategies in Implementing Novel Kidney Protective and Cardioprotective Therapies in Patients With Diabetes and Kidney Disease, Christine P. Limonte et.al. Seminar Nephrology 2024.
- CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease, Hans- Joachim Anders et.al. Natures Review.
- Proteinuric and Non-Proteinuric Diabetic Kidney Disease: Different Presentations of the Same Disease?, Larissa Fabre et.al. MDPI 2024.
Targeted identification of risk and treatment of diabetic kidney disease, Sarah Glastras et.al. Natures Review 2023.
- Diabetic kidney disease, Merlin C. Thomas et.al. Natures Review Primer 2015.
- Kidney Biopsy Findings Among Patients With Diabetes in the Cleveland Clinic Kidney Biopsy Epidemiology Project, Alvin G. Kwon et.al. Kidney Medicine 2024.
- Treatment of Diabetic Kidney Disease: Current and Future, Tomotaka Yamazaki et.al. DMJ 2021.
- Update on diagnosis, pathophysiology, and management of diabetic kidney disease, Mai Sugahara et.al; Nephrology 2021.
- Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection, Alessio Mazzieri et.al ; MDPI 2024.
- Intensive Blood-Pressure Control in Patients with Type 2 Diabetes, Y. Bi, M. Li et.al. NEJM 2024.
- Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease, EMPA KIDNEY Group; NEJM 2024.
- New and emerging therapies for diabetic kidney disease, Ricardo Correa-Rotter et.al. Natures Review 2024.
- Pathologic Classification of Diabetic Nephropathy, Thijs W. Cohen Tervaert et.al; JASN 2021.
- Targeting the Pathobiology of Diabetic Kidney Disease, Merlin C. Thomas et,al; ACKD 2021.
- Prevalence and Factors Predicting Nondiabetic Kidney Disease in Type 2 Diabetic Patients, Vignesh Subramani et.al. IJKD 2024.
- Transplant Options for Patients With Diabetes and Advanced Kidney Disease: A Review, Aleksandra Kukla et.al. AJKD 2021.
